Cargando…

Diagnostic Accuracy of a CA125-Based Biomarker Panel in Patients with Pancreatic Cancer: A Systematic Review and Meta-Analysis

Background: Increasing evidence from recent studies has revealed the association of CA125 with the diagnosis of pancreatic cancer, but inconsistent findings have been reported. We aimed to evaluate the diagnostic value of a serum CA125-based diagnostic panel in predicting malignant pancreatic cancer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meng, Qingcai, Shi, Si, Liang, Chen, Xiang, Jinfeng, Liang, Dingkong, Zhang, Bo, Qin, Yi, Ji, Shunrong, Xu, Wenyan, Xu, Jin, Ni, Quanxing, Yu, Xianjun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5687178/ https://www.ncbi.nlm.nih.gov/pubmed/29151947 http://dx.doi.org/10.7150/jca.18901

Ejemplares similares

Diagnostic and prognostic value of carcinoembryonic antigen in pancreatic cancer: a systematic review and meta-analysis
por: Meng, Qingcai, et al.
Publicado: (2017)

Complex roles of the stroma in the intrinsic resistance to gemcitabine in pancreatic cancer: where we are and where we are going
por: Liang, Chen, et al.
Publicado: (2017)

TCF7L2 positively regulates aerobic glycolysis via the EGLN2/HIF-1α axis and indicates prognosis in pancreatic cancer
por: Xiang, Jinfeng, et al.
Publicado: (2018)

FBW7 increases the chemosensitivity of pancreatic cancer cells to gemcitabine through upregulation of ENT1
por: Hu, Qiangsheng, et al.
Publicado: (2017)

Current status and dilemma of second-line treatment in advanced pancreatic cancer: is there a silver lining?
por: Hua, Jie, et al.
Publicado: (2018)

ERK kinase phosphorylates and destabilizes the tumor suppressor FBW7 in pancreatic cancer
por: Ji, Shunrong, et al.
Publicado: (2015)

Noncoding RNAs as potential biomarkers to predict the outcome in pancreatic cancer
por: Jin, Kaizhou, et al.
Publicado: (2015)

GPx1 is involved in the induction of protective autophagy in pancreatic cancer cells in response to glucose deprivation
por: Meng, Qingcai, et al.
Publicado: (2018)

dCK negatively regulates the NRF2/ARE axis and ROS production in pancreatic cancer
por: Hu, Qiangsheng, et al.
Publicado: (2018)

Nab-paclitaxel plus gemcitabine as first-line treatment for advanced pancreatic cancer: a systematic review and meta-analysis
por: Zhang, Yiyin, et al.
Publicado: (2019)

Profilin-1 suppresses tumorigenicity in pancreatic cancer through regulation of the SIRT3-HIF1α axis
por: Yao, Wantong, et al.
Publicado: (2014)

MBD1 promotes the malignant behavior of gallbladder cancer cells and induces chemotherapeutic resistance to gemcitabine
por: Wensheng, Liu, et al.
Publicado: (2019)

PRMT5 enhances tumorigenicity and glycolysis in pancreatic cancer via the FBW7/cMyc axis
por: Qin, Yi, et al.
Publicado: (2019)

Nipple Discharge of CA15-3, CA125, CEA and TSGF as a New Biomarker Panel for Breast Cancer
por: Wang, Gangping, et al.
Publicado: (2014)

ABO Blood Group and the Risk of Pancreatic Neoplasms in Chinese Han Population: A Study at Shanghai Pancreatic Cancer Institute
por: Liu, Mengqi, et al.
Publicado: (2019)

Clinical implication of serum CA125 for the prediction of malignancy in mucinous cystic neoplasms of the pancreas
por: Deng, Shengming, et al.
Publicado: (2020)

M-CSF in a new biomarker panel with HE4 and CA 125 in the diagnostics of epithelial ovarian cancer patients
por: Będkowska, Grażyna Ewa, et al.
Publicado: (2015)

The Diagnostic Accuracy of Combined Enolase/Cr, CA125, and CA19-9 in the Detection of Endometriosis
por: Rokhgireh, Samaneh, et al.
Publicado: (2020)

A Panel of CA19-9, Ca125, and Ca15-3 as the Enhanced Test for the Differential Diagnosis of the Pancreatic Lesion
por: Hogendorf, Piotr, et al.
Publicado: (2017)

Inflammatory cytokines and combined biomarker panels in pancreatic ductal adenocarcinoma: Enhancing diagnostic accuracy
por: Kruger, Deirdré, et al.
Publicado: (2019)

CLIC1 and CLIC4 complement CA125 as a diagnostic biomarker panel for all subtypes of epithelial ovarian cancer
por: Singha, Bipradeb, et al.
Publicado: (2018)

Preoperative Biomarker Panel, Including Fibrinogen and FVIII, Improves Diagnostic Accuracy for Pancreatic Ductal Adenocarcinoma
por: Mattila, Nora, et al.
Publicado: (2018)

Value of CA-125 Glycoprotein in Predicting Acute Appendicitis; a Diagnostic Accuracy Study
por: Pouraghaei, Mahboub, et al.
Publicado: (2019)

Expression of CA125 in pancreatic carcinoma and chronic pancreatitis.
por: Macdonald, F., et al.
Publicado: (1988)

Minimally invasive enucleation of pancreatic tumors: The main pancreatic duct is no longer a restricted area
por: Li, Zheng, et al.
Publicado: (2023)

Serum CA125 is a novel predictive marker for pancreatic cancer metastasis and correlates with the metastasis-associated burden
por: Liu, Liang, et al.
Publicado: (2016)

Cuproptosis-Related Gene DLAT as a Novel Biomarker Correlated with Prognosis, Chemoresistance, and Immune Infiltration in Pancreatic Adenocarcinoma: A Preliminary Study Based on Bioinformatics Analysis
por: Fang, Zengli, et al.
Publicado: (2023)

The role of ferroptosis regulators in the prognosis, immune activity and gemcitabine resistance of pancreatic cancer
por: Tang, Rong, et al.
Publicado: (2020)

Pevonedistat Suppresses Pancreatic Cancer Growth via Inactivation of the Neddylation Pathway
por: Xu, Junfeng, et al.
Publicado: (2022)

Combined panel of serum human tissue kallikreins and CA-125 for the detection of epithelial ovarian cancer
por: Koh, Stephen Chee Liang, et al.
Publicado: (2012)

Role of hepatocyte nuclear factor 4 alpha in cell proliferation and gemcitabine resistance in pancreatic adenocarcinoma
por: Sun, Qiqing, et al.
Publicado: (2019)

Emerging roles of the solute carrier family in pancreatic cancer
por: Wu, Zijian, et al.
Publicado: (2021)

Glutamine is a substrate for glycosylation and CA19-9 biosynthesis through hexosamine biosynthetic pathway in pancreatic cancer
por: Liu, Chen, et al.
Publicado: (2023)

Utility of serological biomarker’ panels for diagnostic accuracy of interstitial lung diseases
por: Bergantini, Laura, et al.
Publicado: (2020)

Diagnostic Accuracy of Blood-Based Biomarker Panels: A Systematic Review
por: Hardy-Sosa, Anette, et al.
Publicado: (2022)

Hyperdense Pancreatic Ductal Adenocarcinoma: Clinical Characteristics and Proteomic Landscape
por: Xu, He, et al.
Publicado: (2021)

The reciprocal regulation between host tissue and immune cells in pancreatic ductal adenocarcinoma: new insights and therapeutic implications
por: Liu, Xiaomeng, et al.
Publicado: (2019)

Preoperative Serum CA125 Levels Predict the Prognosis in Hyperbilirubinemia Patients With Resectable Pancreatic Ductal Adenocarcinoma
por: Chen, Tao, et al.
Publicado: (2015)

Molecular Mechanism Underlying Lymphatic Metastasis in Pancreatic Cancer
por: Xiao, Zhiwen, et al.
Publicado: (2014)

Application of “Papillary-Like Main Pancreatic Duct Invaginated” Pancreaticojejunostomy for Normal Soft Pancreas Cases
por: Zhang, Bo, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_t9ho5erra0k3233pe5ivg4aug2